PHYLANTHUS AMARUS: ACTIVE CONSTITUENTS AND EFFECTS ON COMMON DISEASES
Main Article Content
Abstract
Objective: To summarize the major bioactive constituents and mechanisms of action of Phyllanthus amarus, and to synthesize the evidence regarding its effects on liver diseases, metabolic disorders, and renal–urinary conditions.
Methods: A structured narrative review was conducted using international databases and selected Vietnamese medical journals up to 30 November 2025. Studies were included when they clearly identified the species or provided separate analysis for P. amarus, and described the preparation/intervention and outcome measures. Evidence was stratified into in vitro, animal, and human levels.
Results: P. amarus contains lignans, polyphenols, flavonoids, tannins, and phenolic acids, and shows antioxidant, anti-inflammatory, immunomodulatory, hepatoprotective, and nephroprotective activities. Preclinical studies showed relatively consistent effects on HBV-related targets, toxic liver injury, insulin resistance, dyslipidemia, and calcium oxalate deposition. Human evidence remains limited and heterogeneous. A 1988 trial reported a high rate of HBsAg loss, but later studies did not reproduce this finding. Systematic reviews rated the certainty of evidence as low because of high risk of bias, mixing of different Phyllanthus species, and lack of product standardization. Short-term tolerability appears acceptable overall, but long-term safety and herb–drug interactions remain unclear.
Conclusion: P. amarus should currently be regarded only as an adjunctive botanical and should not replace standard therapy. Further randomized double-blind trials using standardized preparations are needed to clarify efficacy and safety.
Article Details
Keywords
Phyllanthus amarus; active constituents; hepatitis B; metabolic disorders; nephrolithiasis.
References
[2] Yeh SF, Hong CY, Huang YL, Liu TY, Choo KB, Chou CK. Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells. Antiviral Research. 1993;20(3):185-192. doi:10.1016/0166-3542(93)90019-F.
[3] Thyagarajan SP, Subramanian S, Thirunalasundari T, Venkateswaran PS, Blumberg BS. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet. 1988;2(8614):764-766. doi:10.1016/S0140-6736(88)92416-6.
[4] Thamlikitkul V, Wasuwat S, Kanchanapee P. Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers. Journal of the Medical Association of Thailand. 1991;74(9):381-385. DOI: không có.
[5] Liu J, Lin H, McIntosh H. Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review. Journal of Viral Hepatitis. 2001;8(5):358-366. doi:10.1046/j.1365-2893.2001.00307.x.
[6] Xia Y, Luo H, Liu JP, Gluud C. Phyllanthus species for chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews. 2011;(4):CD008960. doi:10.1002/14651858.CD008960.pub2.
[7] Ly HC, Nguyen NPT, Nguyen HTT, et al. Comparison of the therapeutic efficacy and safety between Tenofovir and the combination of Tenofovir and Phyllanthus Amari in treatment of chronic hepatitis B. Medical and Pharmaceutical Research. 2023;7(3):99-108. doi:10.32895/UMP.MPR.7.3.14.
[8] Adeneye AA. The leaf and seed aqueous extract of Phyllanthus amarus improves insulin resistance diabetes in experimental animal studies. Journal of Ethnopharmacology. 2012;144(3):705-711. doi:10.1016/j.jep.2012.10.017.
[9] Woottisin S, Yararom A, Sriprang N, Schmehl O. Effects of Orthosiphon grandiflorus, Hibiscus sabdariffa and Phyllanthus amarus extracts on risk factors for urinary calcium oxalate stones in rats. Journal of Urology. 2011;185(1):323-328. doi:10.1016/j.juro.2010.09.003.
[10] Husain I, Abdulrahman B, Dale OR, et al. Interaction of Phyllanthus amarus extract and its lignans with human xenobiotic sensing receptors and downstream genes. Journal of Ethnopharmacology. 2025;339:119142. doi:10.1016/j.jep.2024.119142.